Effect of Intravenous Acetaminophen on Postoperative Opioid-related Complications
Some patients have respiratory depression (decreased breaths per minute) after surgery. Acetaminophen, an FDA approved pain medication, may prevent this problem. The purpose of this study is to determine if acetaminophen decreases respiratory depression after surgery. The investigators will also evaluate the cost effectiveness of acetaminophen.
Patients having elective major abdominal surgery are being asked to participate in this research study. If eligible, a patient will have their baseline tidal volume (amount of air moved into or out of the lungs) and vital capacity (how much air the lungs are capable of holding) measured using a spirometer (apparatus for measuring the volume of air inspired and expired by the lungs) measured before surgery. Three questionnaires will also need to be completed before surgery.
The patient will then be randomized, like flipping a coin, to receive either Acetaminophen or placebo (inactive substance) as an infusion throughout surgery and for the first two days thereafter. Neither the patient nor his or her physician will know if the patient is assigned to study drug or placebo. Regardless of study assignment, both groups will receive standard pain management medications and sedation.
After surgery, the patient's blood pressure, activity, posture, respiratory rate, the electrical activity of the heart, oxygen saturation, tidal volume, minute ventilation and respiratory rate will be continuously monitored and recorded for 48 hours using a wireless pulse-oximeter and a respiratory volume monitor.
48 hours after surgery the patient will be asked to complete a patient satisfaction questionnaire, which will allow the patient to rate the satisfaction with the treatment received for pain. The patient will also be asked to complete a questionnaire about recovery.
At discharge, the patient will be given two questionnaires about pain and quality of life.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
Ohio
-
Cleveland, Ohio, États-Unis, 44195
- Cleveland Clinic Foundation
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Written informed consent
- 18-85 years old
- above 50 kg
- American Society of Anaesthesiologists Physical Status 1-3
- Scheduled for elective open or laparoscopic abdominal surgery, including colorectal, prostate, and hysterectomy surgeries
- Patients with anticipated hospitalization of two nights
- Expected to require parenteral opioids for at least 48 hours for postoperative pain
- Able to use IV Patient-Controlled Analgesia systems
Exclusion Criteria:
- Hepatic disease, e.g. twice the normal levels of liver enzymes
- Kidney disease, e.g. twice the normal level of serum creatinine
- Epidural analgesia or regional blocks (including Transverse abdominis plane block)
- Acetaminophen sensitivity or known allergy
- Female patients who are pregnant or breastfeeding
- Patients taking warfarin
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: Intravenous 0.9% sodium chloride
0.9% sodium chloride infusion will be initiated before the surgical incision with 100 ml and repeated every 6 hours for the earlier of 48 postoperative hours of hospital discharge.
|
|
|
Expérimental: Intravenous Acetaminophen
Acetaminophen infusion will be initiated before the surgical incision with 1 g and repeated every 6 hours for the earlier of 48 postoperative hours of hospital discharge.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Duration of Hypoxemia
Délai: the initial 48 hours of postoperative monitoring or for the duration of hospitalization, if shorter.
|
Hypoxemia is measured as minutes with hypoxemia (Spo2 <90%) per hour of successful Spo2 monitoring.
Patients will have nearly continuous pulseoximeter monitoring and recording.
Data from the monitor will be downloaded daily for 48 hours postoperatively.
|
the initial 48 hours of postoperative monitoring or for the duration of hospitalization, if shorter.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Time-weighted Pain Score During Initial 48 Postoperative Hours
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
Pain scores were calculated on a visual analog scale of 0 to 10, with 0 being no pain and 10 being the most pain imaginable; time weighted mean was calculated as the area under the curve of the pain score measurements divided by total measurement time.
Pain was recorded at roughly 15-minute intervals in the postanesthesia care unit and at 4-hour intervals on surgical wards
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Time Weighted Pain Score in Post Anesthesia Care Unit
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
Pain scores were calculated on a visual analog scale of 0 to 10, with 0 being no pain and 10 being the most pain imaginable; time-weighted mean was calculated as the area under the curve of the pain score measurements divided by total measurement time.
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Fatigue Score on Morning of Postoperative Day 1
Délai: Postoperative day 1
|
Fatigue scores were calculated on a scale of 1 to 10, with 1 being no fatigue and 10 being the worst fatigue imaginable.
|
Postoperative day 1
|
|
Lowest RASS Score During Initial 48 Postoperative Hours
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
Sedation was estimated by the RASS score and recorded at 2-hour intervals by ward nurses per clinical routine during the initial 48 postoperative hours.
The Richmond Agitation-Sedation Scale (RASS) is scored from -5 to +4, with -5 being unarousable, 0 being alert and calm, and +4 being combative.
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Time Spent in Sitting or Upright Position
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
Treatment effect data are reported as ratios of geometric means
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Opioid Consumption - Intravenous Morphine Equivalents
Délai: Initial 48 postoperative hours
|
Total opioid consumption over the initial 48 postoperative hours was extracted from patients' medical records and converted to intravenous morphine equivalents
|
Initial 48 postoperative hours
|
|
Incidence of Postoperative Nausea and Vomiting
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
Patients were asked about postoperative nausea and vomiting in the postanesthesia care unit, at 4-hour intervals while awake through the remaining initial day of surgery, and on the first and second postoperative mornings.
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Incidence of Low Respiratory Function Event
Délai: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
A low respiratory function event was defined as an episode of less than 40% of predicted minute ventilation for 2 minutes.
|
Initial 48 postoperative hours or duration of hospitalization (whichever comes first)
|
|
Total Anesthetic Dose From Induction to Extubation
Délai: Induction to extubation (3 hours on average)
|
Total anesthetic dose is measured in minimal alveolar concentration hours.
|
Induction to extubation (3 hours on average)
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 14-241
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .